Who is the CEO of K Pharma,Inc.?

The CEO of K Pharma,Inc. is Hiroaki Fukushima.

What industry does K Pharma,Inc. belong to?

K Pharma,Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is K Pharma,Inc. headquartered?

K Pharma,Inc. is headquartered at Tri-Seven Roppongi, Minato-ku, 106-0032, JP.

What is the IPO date of K Pharma,Inc.?

K Pharma,Inc. went public on October 17, 2023.

How many employees does K Pharma,Inc. have?

K Pharma,Inc. has approximately 17 full-time employees.

K Pharma,Inc.

4896.T•JPX

Healthcare

Biotechnology

¥725.00

¥-10.00(-1.36%)

K Pharma,Inc. (4896.T) Company Profile & Overview

Explore K Pharma,Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

K Pharma,Inc. (4896.T) Company Profile & Overview

K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.

SectorHealthcare

IndustryBiotechnology

CEOHiroaki Fukushima

Contact Information

https://www.kpharma.co.jp

Tri-Seven Roppongi, Minato-ku, 106-0032

Company Facts

17 Employees

IPO DateOct 17, 2023

CountryJP

Actively Trading

Frequently Asked Questions

;